Zobrazeno 1 - 4
of 4
pro vyhledávání: '"James Malar"'
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 3 (2023)
Externí odkaz:
https://doaj.org/article/b691d8cb283c4a9ebb7624af552acabb
Autor:
Brian Citro, Viorel Soltan, James Malar, Thandi Katlholo, Caoimhe Smyth, Ani Herna Sari, Olya Klymenko, Maxime Lunga
Publikováno v:
Health and Human Rights, Vol 23, Iss 2, Pp 253-267 (2020)
The global tuberculosis (TB) response has undergone a transformation in recent years. Calls for a paradigm shift have inspired a new focus on the importance of communities, human rights, and gender in the response. This focus has led to new approache
Externí odkaz:
https://doaj.org/article/b5aed96084b24fbe8b0856ae7d8c0dc2
Autor:
Alexandra J. Zimmer, Petra Heitkamp, James Malar, Cintia Dantas, Kate O'Brien, Aakriti Pandita, Robyn C. Waite
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 24, Iss , Pp 100248- (2021)
Facility-based directly observed therapy (DOT) has been the standard for treating people with TB since the early 1990s. As the commitment to promote a people-centred model of care for TB grows, the use of facility-based DOT has been questioned as iss
Externí odkaz:
https://doaj.org/article/219c107936d34a068cf815ce09aae8ea
Autor:
Alasdair Reid, Adeeba Kamarulzaman, Timur Abdullaev, James Malar, Teri Roberts, Suvanand Sahu, Yogan Pillay, Paula I Fujiwara, Satvinder Singh, Sevim Ahmedov, Shannon Hader, Wim Vandevelde
Publikováno v:
Journal of the International AIDS Society
Introduction Until COVID‐19, tuberculosis (TB) was the leading infectious disease killer globally, disproportionally affecting people with HIV. The COVID‐19 pandemic is threatening the gains made in the fight against both diseases. Discussion Alt